Status:
UNKNOWN
Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies
Lead Sponsor:
Heidelberg University
Conditions:
Covid19
Kidney Transplant; Complications
Eligibility:
All Genders
18-75 years
Brief Summary
The Covid-19 Serum Study is a prospective case-control study in 1. kidney or liver transplanted patients being hospitalized due to an infection with Severe Acute Respiratory Syndrome Coronavirus Type...
Eligibility Criteria
Inclusion
- Kidney-transplant recipients and full-size liver-recipients (de-novo or re-transplanted)
- Participant or legal guardian is willing and able to give informed consent for participation in the trial
- SARS-CoV-2 infection before transplantation (PRE-TX Covid-19 Serum Study) or after transplantation (POST-TX Covid-19 Serum Study)
- Specific Inclusion Criteria for PRE-TX Covid-19 Serum Study:
- Kidney or liver transplantation between Dec 17,2020 - Dec 17, 2021
- Specific Inclusion Criteria for POST-TX Covid-19 Serum Study:
- Hospitalization due to SARS-CoV-2 infection in between Dec 17,2020 - Dec 17, 2021
Exclusion
- Participants not meeting the inclusion criteria
- multi-organ transplant recipients
Key Trial Info
Start Date :
December 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 28 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04694573
Start Date
December 28 2020
End Date
December 28 2022
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nierenzentrum Heidelberg
Heidelberg, DE, Germany, 69120